Seeking Alpha

Tonix Pharmaceuticals closes it public offering

  • Tonix Pharmaceuticals Holding (TNXP -2.3%) slips after announcing the closing of its 2.6M share public offering of $4.25 per unit, with each unit consisting of one share of common stock and one warrant to purchase one share of common stock.
  • The company expects to use net proceeds from this offering to fund the clinical development of TNX-102 SL, for which a Phase 2b/3 clinical trial for the treatment of fibromyalgia is in process to begin in the Q313.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio: